Loading…
Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban)
van der Hoorn, José W, Jukema, J Wouter, Bekkers, Marian E, Princen, Hans M, Corda, Stefano, Emeis, Jeff J, Steendijk, Paul
Published in Critical care medicine (01.09.2008)
Published in Critical care medicine (01.09.2008)
Get more information
Journal Article
Loading…
Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers
Van Ryn, Joanne, Kink-Eiband, Monika, Kuritsch, Ingrid, Feifel, Ulrich, Hanft, Gertraud, Wallenstein, Gudrun, Trummlitz, Guenter, Pairet, Michel
Published in Journal of clinical pharmacology (01.07.2004)
Published in Journal of clinical pharmacology (01.07.2004)
Get more information
Journal Article
Loading…
Loading…
Effect of COX-2 inhibitor after TNBS-induced colitis in wistar rats
Paiotti, Ana Paula Ribeiro, Miszputen, Sender Jankiel, Oshima, Celina Tizuko Fujiyama, de Oliveira Costa, Henrique, Ribeiro, Daniel Araki, Franco, Marcello
Published in Journal of molecular histology (01.08.2009)
Published in Journal of molecular histology (01.08.2009)
Get full text
Journal Article
Loading…
Upper gastrointestinal hemorrhage: Have new therapeutics made a difference?
Whelan, Chad T., Kaboli, Peter, Zhang, Qi, Siddique, Juned, Ye, Siqin, Meltzer, David O.
Published in Journal of hospital medicine (01.09.2009)
Published in Journal of hospital medicine (01.09.2009)
Get full text
Journal Article
Loading…
Helicobacter Pylori Infection Causes Persistent Platelet Activation In Vivo Through Enhanced Lipid Peroxidation
Davì, Giovanni, Neri, Matteo, Falco, Angela, Festi, Davide, Taraborelli, Tea, Ciabattoni, Giovanni, Basili, Stefania, Cuccurullo, Franco, Patrono, Carlo
Published in Arteriosclerosis, thrombosis, and vascular biology (01.01.2005)
Published in Arteriosclerosis, thrombosis, and vascular biology (01.01.2005)
Get full text
Journal Article
Loading…
COX-2 is not involved in thromboxane biosynthesis by activated human platelets
Patrignani, P, Sciulli, M G, Manarini, S, Santini, G, Cerletti, C, Evangelista, V
Published in Journal of physiology and pharmacology : an official journal of the Polish Physiological Society (01.12.1999)
Get full text
Published in Journal of physiology and pharmacology : an official journal of the Polish Physiological Society (01.12.1999)
Journal Article
Loading…
Bringing evidence to practice: obstacles and barriers
Niebling, Wilhelm
Published in Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen (2011)
Published in Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen (2011)
Get full text
Journal Article
Loading…
Effects of non‐steroidal anti‐inflammatory drugs on cyclo‐oxygenase and lipoxygenase activity in whole blood from aspirin‐sensitive asthmatics vs healthy donors
Gray, P A, Warner, T D, Vojnovic, I, Del Soldato, P, Parikh, A, Scadding, G K, Mitchell, J A
Published in British journal of pharmacology (01.12.2002)
Published in British journal of pharmacology (01.12.2002)
Get full text
Journal Article
Loading…
Loading…
Loading…
Loading…
Effects of selective cyclooxygenase isoform inhibition on systemic prostacyclin synthesis and on platelet function at rest and after exercise in healthy volunteers
Weber, Artur-Aron, Heim, Hans-Karl, Schumacher, Marc, Schrör, Karsten, Hohlfeld, Thomas
Published in Platelets (Edinburgh) (01.01.2007)
Published in Platelets (Edinburgh) (01.01.2007)
Get full text
Journal Article
Loading…
Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2—specific inhibitor, compared with ketorolac, naproxen, and placebo
Harris, Stuart I, Kuss, Michael, Hubbard, Richard C, Goldstein, Jay L
Published in Clinical therapeutics (01.09.2001)
Published in Clinical therapeutics (01.09.2001)
Get full text
Journal Article
Loading…
Loading…
A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers
Greenberg, H E, Gottesdiener, K, Huntington, M, Wong, P, Larson, P, Wildonger, L, Gillen, L, Dorval, E, Waldman, S A
Published in Journal of clinical pharmacology (01.12.2000)
Published in Journal of clinical pharmacology (01.12.2000)
Get more information
Journal Article
Loading…
Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo
Karjalainen, Marjo J., Neuvonen, Pertti J., Backman, Janne T.
Published in European journal of clinical pharmacology (01.05.2008)
Published in European journal of clinical pharmacology (01.05.2008)
Get full text
Journal Article
Loading…
Pain relief model for a COX‐2 inhibitor in patients with postoperative dental pain
Rohatagi, Shashank, Kastrissios, Helen, Sasahara, Kunihiro, Truitt, Kenneth, Moberly, James B., Wada, Russell, Salazar, Daniel E.
Published in British journal of clinical pharmacology (01.07.2008)
Published in British journal of clinical pharmacology (01.07.2008)
Get full text
Journal Article